Recent studies have also shown that silencing LAPTM4B remarkably reduces the expression of VEGF in HeLa cells [17] and that increased LAPTM4B-35 combined with positive VEGF expression might serve as a new biological marker to predict outcomes in cervical carcinoma [18]. The gene discussed is LAPTM4B; the disease is cervical carcinoma.